IMPACT Trial: Intervention to iMProve AdherenCe equitably
Intervention to Improve Medication Scheduling for Patients with Breast Cancer
Sponsor: NIH
Enrolling: Male and Female Patients
IRB Number: AAAT8817
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: Many patients with breast cancer, who also take medicine to prevent heart disease such as a blood pressure medicine or a cholesterol medicine, experience frustration with the large number and difficult scheduling of their medications, known as pill burden. This study will help us find out how much pill burden exists in subjects with cancer at various stages, and how this intervention can help. Results of this study may help us figure out the best way to help patients manage their medications in the future.
Investigator
Dawn Hershman, MD
Do You Qualify?
Have you been diagnosed with breast cancer? Yes No
Do you speak English? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162